Arbutus Biopharma Corp (Nasdaq:ABUS)

Health Care/Life Sciences • Pharmaceuticals

CIK 1447028

Company

Arbutus Biopharma Corp. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics that target specific viral diseases. It focuses on the Hepatitis B virus, SARS-CoV-2, and other coronaviruses. The company was founded on October 6, 2005 and is headquartered in Warminster, PA.

Address
701 Veterans Circle
Warminster, Pennsylvania 18974

Employees
73

Stock Info

Close
$3.4600

Day Range
3.3200 - 3.4800

52 Week Range
2.3000 - 4.7250

Average volume
827.74K

Short Interest
7.21M (02/14/25)

% of Float Shorted
4.90%

Market Cap
$655.64M

Revenue
$18.14M

Net Income
-$72.85M

2020 Sales Growth
N/A

Rev. per Employee
N/A

P/E Ratio
N/A

EPS
-$0.4260

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Director
Anuj Hasija

Director
Robert Alan Beardsley

None
James R. Meyers

None
Richard C. Henriques Jr.

SEC filings

Date	Form	Event
5 Dec, 2024	EFFECT
15 Nov, 2024	8-K
14 Nov, 2024	SC 13G/A
6 Nov, 2024	8-K
6 Nov, 2024	S-3
6 Nov, 2024	10-Q
15 Oct, 2024	8-K
11 Oct, 2024	8-K
16 Aug, 2024	4
8 Aug, 2024	S-8
8 Aug, 2024	10-Q
5 Aug, 2024	8-K
1 Aug, 2024	8-K
10 Jun, 2024	SC 13G
6 Jun, 2024	8-K
5 Jun, 2024	8-K
28 May, 2024	8-K
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
24 May, 2024	4
22 May, 2024	8-K
17 May, 2024	SC 13D/A
9 May, 2024	SC 13D
2 May, 2024	8-K
2 May, 2024	10-Q
2 May, 2024	8-K
10 Apr, 2024	DEFA14A
10 Apr, 2024	DEF 14A
4 Apr, 2024	8-K
5 Mar, 2024	10-K
29 Feb, 2024	8-K
14 Feb, 2024	SC 13G/A
14 Feb, 2024	SC 13G/A
12 Feb, 2024	SC 13G/A
5 Feb, 2024	4
5 Feb, 2024	4
5 Feb, 2024	4
5 Feb, 2024	4
5 Feb, 2024	4
8 Jan, 2024	8-K
4 Jan, 2024	8-K	CEO Change
21 Nov, 2023	SC 13G
9 Nov, 2023	8-K
7 Nov, 2023	8-K	CEO Change
7 Nov, 2023	10-Q
7 Nov, 2023	8-K
11 Oct, 2023	8-K
11 Sep, 2023	8-K
11 Sep, 2023	SC 13G
3 Aug, 2023	S-8
3 Aug, 2023	10-Q
3 Aug, 2023	8-K
13 Jul, 2023	4
13 Jul, 2023	3
12 Jul, 2023	8-K
12 Jul, 2023	3
12 Jul, 2023	3
12 Jul, 2023	4
12 Jul, 2023	4
10 Jul, 2023	8-K
21 Jun, 2023	8-K
21 Jun, 2023	8-K
7 Jun, 2023	8-K
30 May, 2023	8-K
26 May, 2023	4
26 May, 2023	4
26 May, 2023	4
26 May, 2023	4
26 May, 2023	4
4 May, 2023	10-Q
4 May, 2023	8-K
27 Apr, 2023	8-K
25 Apr, 2023	8-K
18 Apr, 2023	8-K
12 Apr, 2023	DEF 14A
12 Apr, 2023	DEFA14A
4 Apr, 2023	8-K
16 Mar, 2023	8-K
14 Mar, 2023	8-K
2 Mar, 2023	10-K
2 Mar, 2023	8-K
3 Feb, 2023	4
3 Feb, 2023	4
3 Feb, 2023	4
3 Feb, 2023	4
3 Feb, 2023	4
3 Feb, 2023	SC 13G
27 Jan, 2023	8-K
5 Jan, 2023	8-K
13 Dec, 2022	8-K
9 Nov, 2022	8-K
9 Nov, 2022	10-Q
4 Nov, 2022	8-K
1 Nov, 2022	8-K
31 Oct, 2022	8-K
24 Oct, 2022	8-K
30 Sep, 2022	8-K
30 Aug, 2022	8-K
4 Aug, 2022	S-8
4 Aug, 2022	10-Q
4 Aug, 2022	8-K
20 Jul, 2022	8-K
27 Jun, 2022	8-K
8 Jun, 2022	8-K
6 Jun, 2022	8-K
31 May, 2022	8-K
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	4
26 May, 2022	8-K
26 May, 2022	4
24 May, 2022	8-K
5 May, 2022	8-K
11 Apr, 2022	DEFA14A
11 Apr, 2022	DEF 14A
3 Mar, 2022	8-K
3 Mar, 2022	8-K
3 Mar, 2022	424B5
3 Mar, 2022	10-K
28 Feb, 2022	8-K
14 Feb, 2022	SC 13G/A
24 Jan, 2022	8-K
20 Jan, 2022	4
20 Jan, 2022	4
20 Jan, 2022	4
20 Jan, 2022	4
20 Jan, 2022	4
20 Jan, 2022	4
30 Dec, 2021	D
14 Dec, 2021	8-K
13 Dec, 2021	8-K
10 Dec, 2021	8-K
7 Dec, 2021	8-K
3 Dec, 2021	4
1 Dec, 2021	8-K
18 Nov, 2021	EFFECT
16 Nov, 2021	UPLOAD
16 Nov, 2021	CORRESP
12 Nov, 2021	8-K
12 Nov, 2021	3
12 Nov, 2021	4
12 Nov, 2021	8-K
4 Nov, 2021	S-3
4 Nov, 2021	8-K
4 Nov, 2021	10-Q
20 Oct, 2021	SC 13D/A
20 Oct, 2021	4
8 Oct, 2021	8-K
8 Oct, 2021	424B5
5 Aug, 2021	S-8
5 Aug, 2021	8-K
5 Aug, 2021	10-Q
14 Jul, 2021	8-K
7 Jul, 2021	8-K
6 Jul, 2021	8-K
29 Jun, 2021	8-K
28 Jun, 2021	8-K
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
7 Jun, 2021	4
1 Jun, 2021	8-K
5 May, 2021	10-Q
5 May, 2021	8-K
8 Apr, 2021	DEFA14A
8 Apr, 2021	DEF 14A
1 Apr, 2021	8-K
16 Mar, 2021	8-K
4 Mar, 2021	8-K
4 Mar, 2021	8-K
4 Mar, 2021	424B5
4 Mar, 2021	10-K
26 Feb, 2021	8-K
17 Feb, 2021	4
17 Feb, 2021	4
17 Feb, 2021	4
17 Feb, 2021	4
17 Feb, 2021	4
17 Feb, 2021	4
16 Feb, 2021	SC 13G/A
12 Feb, 2021	SC 13G/A
10 Feb, 2021	SC 13G/A
10 Feb, 2021	4
1 Feb, 2021	8-K
25 Jan, 2021	8-K

Last update:2025-03-06 12:15:02.185605

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.